As shown in the mechanism diagram, androgen led to the dysfunction and exhaustion of CD8+ T-cells in the TME of male RCC, while ARi activated CD8+ T-cells and enhanced the efficacy of immunotherapy (Fig. 6F). This evidence concerns the gene ARIH1 and renal cell carcinoma.